GW9662 treatment distinctly aggravated the decreased PPAR-γ expression levels and increased STAT3 and NF-κB phosphorylation in gastrocnemius muscles of LLC tumor–bearing mice as shown by the Western blot (Figure 5K). This evidence concerns the gene NFKB1 and neoplasm.